Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Nature Medicine
|
August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial
Franco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Neuro-Oncology
|
December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
Emmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Acta Neuropathologica
|
July 24, 2021
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling
Francesca Nazio, Agnese Po, Luana Abballe, et al.
Cell Death Discovery
|
August 6, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks
Matteo Cassandri, Antonella Porrazzo, Silvia Pomella, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?
Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Haematologica
|
May 9, 2020
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells
Marika Guercio, Domenico Orlando, Stefano Di Cecca, et al.
Journal of Hematology & Oncology
|
December 19, 2024
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells
Michele Pezzella, Concetta Quintarelli, Maria C Quadraccia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2024
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
Roselia Ciccone, Concetta Quintarelli, Antonio Camera, et al.
Frontiers in Oncology
|
May 1, 2020
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Dominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Frontiers in Oncology
|
July 14, 2020
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Dominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Nature Medicine
|
August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial
Franco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Neuro-Oncology
|
December 29, 2021
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant
Emmanuel de Billy, Marsha Pellegrino, Domenico Orlando, et al.
Acta Neuropathologica
|
July 24, 2021
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling
Francesca Nazio, Agnese Po, Luana Abballe, et al.
Cell Death Discovery
|
August 6, 2024
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks
Matteo Cassandri, Antonella Porrazzo, Silvia Pomella, et al.
Journal for Immunotherapy of Cancer
|
May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?
Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Haematologica
|
May 9, 2020
CD28.OX40 co-stimulatory combination is associated with long in vivo persistence and high activity of CAR.CD30 T-cells
Marika Guercio, Domenico Orlando, Stefano Di Cecca, et al.
Journal of Hematology & Oncology
|
December 19, 2024
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells
Michele Pezzella, Concetta Quintarelli, Maria C Quadraccia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2024
GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma
Roselia Ciccone, Concetta Quintarelli, Antonio Camera, et al.
Frontiers in Oncology
|
May 1, 2020
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Dominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Frontiers in Oncology
|
July 14, 2020
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Dominga Racanelli, Monica Brenca, Davide Baldazzi, et al.
Page
of 7